These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

531 related items for PubMed ID: 10365406

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Assessment and monitoring of onchocerciasis in Latin America.
    Rodríguez-Pérez MA, Unnasch TR, Real-Najarro O.
    Adv Parasitol; 2011; 77():175-226. PubMed ID: 22137585
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of onchocerciasis seroprevalence in Bioko Island (Equatorial Guinea) after years of disease control programmes.
    Hernández-González A, Moya L, Perteguer MJ, Herrador Z, Nguema R, Nguema J, Aparicio P, Benito A, Gárate T.
    Parasit Vectors; 2016 Sep 20; 9(1):509. PubMed ID: 27645887
    [Abstract] [Full Text] [Related]

  • 5. Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin.
    Komlan K, Vossberg PS, Gantin RG, Solim T, Korbmacher F, Banla M, Padjoudoum K, Karabou P, Köhler C, Soboslay PT.
    PLoS Negl Trop Dis; 2018 Mar 20; 12(3):e0006312. PubMed ID: 29494606
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Population dynamics of onchocerca volvulus microfilariae in human host after six years of drug control.
    Opara KN, Fagbemi BO.
    J Vector Borne Dis; 2008 Mar 20; 45(1):29-37. PubMed ID: 18399314
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Modelling exposure heterogeneity and density dependence in onchocerciasis using a novel individual-based transmission model, EPIONCHO-IBM: Implications for elimination and data needs.
    Hamley JID, Milton P, Walker M, Basáñez MG.
    PLoS Negl Trop Dis; 2019 Dec 20; 13(12):e0007557. PubMed ID: 31805049
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Importance of migrants infected with Onchocerca volvulus in west African river valleys protected by 14 to 15 years of Simulium control.
    De Sole G, Remme J.
    Trop Med Parasitol; 1991 Jun 20; 42(2):75-8. PubMed ID: 1654591
    [Abstract] [Full Text] [Related]

  • 14. Onchocerca ochengi: epidemiological evidence of cross-protection against Onchocerca volvulus in man.
    Wahl G, Enyong P, Ngosso A, Schibel JM, Moyou R, Tubbesing H, Ekale D, Renz A.
    Parasitology; 1998 Apr 20; 116 ( Pt 4)():349-62. PubMed ID: 9585937
    [Abstract] [Full Text] [Related]

  • 15. Seventeen years of annual distribution of ivermectin has not interrupted onchocerciasis transmission in North Region, Cameroon.
    Katabarwa MN, Eyamba A, Nwane P, Enyong P, Yaya S, Baldiagaï J, Madi TK, Yougouda A, Andze GO, Richards FO.
    Am J Trop Med Hyg; 2011 Dec 20; 85(6):1041-9. PubMed ID: 22144441
    [Abstract] [Full Text] [Related]

  • 16. Recrudescence of onchocerciasis in the Comoé valley in Southwest Burkina Faso.
    Koala L, Nikiema A, Post RJ, Paré AB, Kafando CM, Drabo F, Traoré S.
    Acta Trop; 2017 Feb 20; 166():96-105. PubMed ID: 27845063
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.